Fiscal period ending 2025-12-31 versus 2024-12-31
— view filing on EDGAR →
FMC's risk profile has deteriorated sharply and broadly, with pervasive worsening spanning solvency signals, strategic dislocation, and competitive erosion simultaneously. A below-investment-grade downgrade, covenant amendments with no assurance of future waivers, a dividend cut, and new liquidity disclosures collectively signal acute financial stress approaching distress territory. Layered on top are a formal strategic review, a major restructuring program, patent expirations on flagship revenue products, and newly disclosed supply chain, regulatory, and geopolitical vulnerabilities across more than five distinct themes.
11 company-specific
· 10 common-mode
Company-specific changes
New
Materialized
Newly disclosed below-investment-grade downgrade with increased borrowing costs, restricted financing access, and new asset lien covenant trigger materially worsen capital structure risk.
Recent credit rating downgrades and potential future downgrades could increase our financing costs and limit access to capital. The major rating agencies routinely evaluate our credit profile and…
Materialized 2026-06-05 · M&A activity
view 8-K →
The risk factor warned that below-investment-grade downgrades would result in higher financing costs and more restrictive terms; the completed $1.2 billion offering of senior secured notes at an 8.000% interest rate directly reflects the increased borrowing costs and secured (more restrictive) terms the risk factor warned about.
The Notes are senior secured obligations of the Company and bear interest at a rate of 8.000% per annum
New
New disclosure of major restructuring program (Project Foundation) announced December 2025 involving plant closures, production transitions, and cost reductions. Material execution risk with potential operational disruption and key personnel loss.
Our financial results could be harmed if we are not successful in executing our strategy and initiatives in connection with our restructuring programs, including Project Foundation. We may need to…
New
New disclosure of material facility interruption and supply chain risks across five key manufacturing locations. Identifies single-source production dependencies and operational hazards that could materially reduce profitability.
Interruptions at our key facilities may materially reduce the productivity of a particular manufacturing facility, or the profitability of our business as a whole. We produce products through a…
New
Company announced formal strategic review in Feb 2026 exploring partnerships, M&A, divestitures. Material uncertainty regarding timing, completion, financing, and employee retention. Stock price volatility risk disclosed.
Risks related to Acquisitions and Divestitures Our exploration of strategic options may not result in entering into or completing transactions, when necessary, and the process of reviewing…
New
Board-approved divestiture of commercial business in India newly disclosed. Execution risk, timeline uncertainty, and potential adverse financial impact are substantive strategic risks.
Our financial results could be harmed if we fail to implement the plan to divest the Company’s commercial business in India in the expected timeline. In July 2025, the Board of Directors approved a…
New
Newly disclosed expiration of composition-of-matter patents on major revenue products (Rynaxypyr, Cyazypyr) and production patents in December 2025 materially increases generic competition and erosion of competitive moat.
The composition of matter patents on our Rynaxypyr ® active and Cyazypyr ® active ingredients have expired in all major markets, which will affect our ability to compete effectively. In addition to…
New
Material: Board significantly reduced quarterly dividend per share beginning January 2026. Dividend cut signals financial stress or capital constraints, directly affecting shareholder returns and investor expectations.
Future cash dividends are subject to final determination by our Board of Directors and are not guaranteed. Future cash dividends depend on a variety of factors, including earnings, capital…
New
New disclosure of covenant compliance risk, recent 2025 amendments to adjust covenants, and explicit warning that future waivers are not assured—signals financial stress and heightened default risk.
Our current indebtedness could have a negative impact on our liquidity or restrict our activities. We plan to meet our liquidity needs through available cash, cash generated from operations and…
New
New disclosure of material tax liability risk from 2019 FMC Lithium spin-off. IRS challenge could result in significant taxable gain and material tax exposure.
The FMC Lithium separation might be interpreted as a taxable event by the IRS or local taxing authorities, subjecting the Company to material tax liabilities. We received an opinion from outside…
New
New disclosure of material IP vulnerability: key diamide insecticide composition patents expired; process/intermediate patents have limited remaining duration. Competitive risk.
Our ability to compete effectively depends on our ability to protect our intellectual property rights. Our innovation efforts are protected by patents, trade secrets and other intellectual property…
New
New disclosure of M&A integration risk, synergy failure, divestiture losses, and impairment charges. Material as it signals active portfolio restructuring with potential earnings and debt impact.
Risks related to Portfolio Management Any failure to realize benefits from acquisitions, alliances or joint ventures or to achieve our portfolio management objectives could adversely affect future…
Also disclosed — common-mode (Data privacy regulation ×2, Tariffs trade policy ×2, Semiconductor supply chain constraints, Geopolitical macro uncertainty, AI cybersecurity escalation, Generative AI competition disruption, ESG regulatory divergence, Debt leverage refinancing)
Data privacy regulation
New
New disclosure of material regulatory risks: pesticide re-registration delays, product cancellations, REACH compliance costs, and litigation exposure in key markets (EU, China, Brazil, Argentina).
Changes in the regulatory environment, particularly in the U.S., Brazil, China, Argentina and the European Union, could adversely impact our ability to continue producing and/or selling certain…
Tariffs trade policy
New
New disclosure of material supply chain vulnerabilities: reliance on China/India suppliers, tariff exposure, Russia-Ukraine conflict impact, recent logistics disruptions and cost inflation. Substantive operational risk.
Changes in the price or availability of key raw materials for production of finished goods have had, and could again have, a material adverse impact on our businesses. Certain raw materials are…
Semiconductor supply chain constraints
New
New disclosure of material transportation dependency risk. Shortage of trucks, railcars, barges, ships could disrupt production, sales, and increase costs materially.
A shortage or unavailability of trucks, railcars, tugs, barges and ships for carrying our products and the raw materials we use in our business could result in customer dissatisfaction, loss of…
Geopolitical macro uncertainty
New
Newly disclosed comprehensive geopolitical and macro risks: tariffs, Russia-Ukraine conflict, Argentina currency/inflation, China supply disruptions, sanctions. Substantive operational and financial exposure.
Our business has been and could continue to be adversely affected by economic and political changes in the markets where we compete. The following have and could continue to adversely affect our…
Tariffs trade policy
New
New disclosure of material tariff and trade war exposure. Company imports from China/India; tariffs already increased costs. Risk of supply disruption and margin pressure is substantive.
Our business is subject to risks associated with sourcing and manufacturing outside of the U.S. and risks from tariffs and/or international trade wars. We import many of our raw materials and…
AI cybersecurity escalation
New
New comprehensive cybersecurity risk disclosure addressing ransomware, data breaches, manufacturing site vulnerabilities, remote work exposure, and regulatory compliance risks with potential material adverse effects.
Our information technology systems and system s operated by our vendors and third parties could be penetrated by outside parties’ intent on observing or gathering information, extracting…
Generative AI competition disruption
New
New disclosure of material competitive threats: generic competition from China, patent expirations, competitor consolidation, and emerging disruptive technologies in agriculture.
Risks Related to Business and Industry Conditions Our business faces competition, which could affect our ability to maintain or raise prices, successfully enter certain markets or retain our market…
ESG regulatory divergence
New
New disclosure of climate risks to operations, supply chain, and demand for crop protection products. Substantive business impact risk warranting investor attention.
Our markets are affected by climatic conditions, both chronic and acute, which could adversely impact our business. Our business may be impacted by changing climate conditions, including physical…
Data privacy regulation
New
New disclosure of PFAS regulatory uncertainty, conflicting definitions across agencies, product restriction/ban risk, litigation exposure, and compliance cost impacts.
Varying definitions in regulations create regulatory uncertainty for our Company when adapting to new environmental rules, including changes to EPA requirements. Regulatory bodies may use different…
Debt leverage refinancing
New
New disclosure of reliance on external financing and credit market access. Addresses liquidity, capital availability, and potential operational restrictions if financing unavailable.
Disruptions in the global credit, financial and/or currency markets could limit our access to credit or otherwise harm our financial results, which could have a material adverse impact on our…